INTRODUCTION
Maintenance of synaptic connections throughout the lifetime of an organism is important for learning, memory, decision making, and adaptive behavioral outputs. Synaptic connectivity is regulated not only by neurons, but also by adjacent non-neuronal cells. Glial cells enhance synaptogenesis to guide the formation of discrete circuits in the developing nervous system (Coló n- Ramos, 2009; Corty and Freeman, 2013) . Astrocytes and microglia modulate synapse formation through many secreted factors, such as hevin, thrombospondins, BDNF, TNFa, and glypican (Bessis et al., 2007; Clarke and Barres, 2013; Stellwagen and Malenka, 2006) . Direct contact between glial cells and axons, partly mediated by protocadherins, integrins, and nectins, is also required for efficient synapse formation (Garrett and Weiner, 2009; Hama et al., 2004; Togashi et al., 2009) . Conversely, glial cells can reduce synapse density through various mechanisms. Astrocytic secretion of SPARC opposes synapse formation by antagonizing hevin-enhanced synaptogenesis (Kucukdereli et al., 2011) . Furthermore, microglia and astrocytes directly eliminate excitatory and inhibitory synapses through distinct phagocytic programs using the complement cascade or MEGF10, respectively (Chung et al., 2013; Schafer et al., 2012) . These functions of non-neuronal cells promote an optimal level of excitatory and inhibitory synapses that is essential for circuit function; deviation from an excitation and inhibition balance has been associated with neurological disorders (Lisman, 2012; Rubenstein, 2010; Stafstrom, 2006) . While many types of interactions between neurons and non-neuronal cells can modulate synaptic connectivity, a gap in our knowledge remains to be how neuron-specific synapse maintenance is achieved at the molecular level.
The immunoglobulin (Ig) domain superfamily (IgSF) is a large, well-conserved family of proteins that regulates many aspects of neural circuit formation, including neurite outgrowth, target identification, and synaptogenesis. Secreted and transmembrane IgSF proteins guide axons and dendrites to precise target areas for synapse formation (Aurelio et al., 2002; Dickson and Gilestro, 2006; Zipursky and Grueber, 2013) . Once pre-and postsynaptic compartments arrive at their target areas, distinct members of IgSF subfamilies, such as Sidekicks and Dscams, specify synaptic connections between neurons in discrete laminae of the retina (Millard et al., 2010; Yamagata and Sanes, 2008; Yamagata et al., 2002) . Additional homophilic and heterophilic interactions between pre-and post-synaptic IgSF molecules, such as SynCAM, NCAM, and nectins, further assist in the formation of synapses (Togashi et al., 2009 ). In the mouse cortex, the L1CAM family of proteins expressed in glial cells facilitates inhibitory synapse formation (Ango et al., 2008) . To date, many cell adhesion molecules, including members of the IgSF, have been identified as intrinsic factors for synapse formation and specification; however, far less is known regarding the roles of IgSF proteins expressed in non-neuronal cells.
C. elegans has a simple nervous system and a small number of non-neuronal cells. Previous studies have shown that expression of the IgSF member SYG-2/Nephrin in the vulval epidermis specifies synapse location of HSN neurons (Shen et al., 2004) . More recently, FGFR expressed in epidermal cells has been shown to regulate glial morphology and in turn synapse location (Shao et al., 2013) .
Here, we use C. elegans as a model to investigate how the interactions between non-neuronal cells and neurons regulate synapse maintenance. In the locomotor circuit, two types of motor neurons form synapses onto body wall muscles and provide cholinergic excitation and GABAergic inhibition that underlie sinusoidal locomotion (Richmond and Jorgensen, 1999; White et al., 1976) . A sheath of epidermal tissue encompasses the nervous system and makes close contact with neuromuscular junctions (NMJs) (White et al., 1986) . We have previously shown that a gain-of-function (gf) mutation in a cholinergically expressed acetylcholine receptor subunit (ACR-2) perturbs the excitation and inhibition balance of the locomotor circuit, resulting in spontaneous convulsions, a genetic model mimicking seizure (Jospin et al., 2009; Stawicki et al., 2011; Zhou et al., 2013) . Interestingly, the convulsion behavior in acr-2(gf) animals can be modulated by ion transport in the epidermis (Stawicki et al., 2011) , indicating that the epidermis regulates the function of the locomotor circuit.
In this study, we have identified the novel two-Ig-domain IgSF member, ZIG-10, which is required for a neuronal-epidermal interaction that continuously maintains the density of excitatory synapses. In the epidermis, ZIG-10 signals through SRC-2 kinase and CED-1 to regulate phagocytic activity. ZIG-10, by controlling cholinergic synapse density, modulates excitation and inhibition balance of the locomotor circuit. Other organisms contain large families of ZIG-10-like proteins, many of which are expressed in neurons and/or glia but whose functions remain mostly unexplored. Our studies reveal the importance of non-neural cells in controlling neuron-type-specific synapse maintenance.
RESULTS

An Epidermal RNAi Screen Identifies zig-10 as a Regulator of Neuromuscular Junctions
To identify genes that function in the epidermis to regulate the locomotor circuit, we designed an RNAi screen in an RNAi-deficient rde-1(lf); acr-2(gf) mutant background, in which wild-type RDE-1 is expressed in the adult epidermis to restore sensitivity to RNAi solely in the epidermis ( Figures 1A and 1B) . acr-2(gf) animals are uncoordinated and exhibit an average of six to eight spontaneous convulsions per minute (Jospin et al., 2009) . We reasoned that knockdown of genes that modulate the locomotor circuit would modify the convulsion frequency. By screening a select set of RNAi clones that target predicted cell surface molecules (Hutter et al., 2000) (Table S1 ), we identified zig-10 (zwei [two] immunoglobulin [Ig] domain protein 10), knockdown of which increased the convulsion frequency in acr-2(gf) animals ( Figure 1C ). ZIG-10 is a member of a family of transmembrane proteins that contain only two extracellular Ig domains; other proteins with similar overall topology include the mammalian junctional adhesion molecules (JAMs) and the Drosophila defective probiscus extension response (DPR) proteins ( Figure 1D ; Figures S1A-S1D) (Rougon and Hobert, 2003) . Proteins of this family generally function as homophilic or heterophilic adhesion molecules (Santoso et al., 2005) but can also act as chaperones , in which RDE-1 was rescued only in adult epidermis (orange), while other tissues remained RNAi defective (gray). (C) zig-10(RNAi) in acr-2(gf) animals increased the frequency of convulsions. (D) The predicted ZIG-10 protein consists of 322 aa and contains two extracellular Ig domains, a transmembrane domain, and a short cytoplasmic tail. There is one class II and three non-canonical SH3-ligand motifs indicated by triangles, as predicted by The Eukaryotic Linear Motif resource for Functional Sites in Proteins (Dinkel et al., 2011) . (E) GFP::ZIG-10 coimmunoprecipitates with HA::ZIG-10 expressed in HEK293T cells. (F) Convulsion frequency analysis in adult animals of genotypes indicated. zig-10(tm6127) is indicated as 0; zig-10(gk144897), lf; + or À denotes presence or absence of GFP::ZIG-10 driven by its endogenous promoter. The data in (C) and (F) are represented as mean ± SEM. **p % 0.01 and ****p % 0.0001. Sample size is indicated within each bar. See also Figure S1 and Table S1. for plasma membrane transporters or integrins (Kobayashi et al., 2014; Mandell et al., 2005) . We tested whether ZIG-10 could form homophilic interactions using a HEK293T cell expression system and found that HA::ZIG-10 and GFP::ZIG-10 could co-immunoprecipitate ( Figure 1E ). We validated RNAi effects using two zig-10 genetic mutations: a null (0) mutation tm6127 and a missense mutation in the first Ig domain, gk144897 (lf) (Figures 1D and 1F ; Figures S1A and S1B; see Experimental Procedures). A null mutation in a closely related gene, zig-1, showed no effect on acr-2(gf) convulsions (Table S1 ; data not shown). Moreover, transgenic expression of wild-type zig-10 fully rescued the enhanced convulsion frequency ( Figure 1F ; Tables  S2 and S3 ).
zig-10 Mutants Display Increased Density of Neuromuscular Junctions
We investigated the localization of ZIG-10 using a GFP::ZIG-10 fusion protein driven by its endogenous promoter ( Figure 2A ). GFP::ZIG-10, which fully rescued zig-10(0) ( Figure 1F ), was visible from late embryonic stages to adult in a subset of head neurons, cholinergic motor neurons in the nerve cord, and the epidermis, including the seam cells (Figures 2B-2D ; Figure S2A ). The subcellular pattern of GFP::ZIG-10 was consistent with plasma membrane localization ( Figure 2D ; Figure S2A ). Around the nerve cord, GFP::ZIG-10 displayed a combination of diffuse and punctate localization at the cell surface ( Figures 2B and 2C) . To determine the localization of ZIG-10 relative to cholinergic synapses, we analyzed transgenic animals that expressed mKate2::ZIG-10 under the zig-10 promoter and UNC-10::GFP in a subset of cholinergic neurons and found that while mKate2:: ZIG-10 was more diffuse than UNC-10::GFP, high levels of mKate2::ZIG-10 tended to be adjacent to UNC-10::GFP ( Figures  2E and 2F ).
To address whether zig-10 mutants affected synapses, we examined the pattern of endogenous UNC-10/RIM, an active zone protein, by immunostaining (Koushika et al., 2001 ). In the wild-type animals, UNC-10 displayed discrete puncta throughout the nervous system, with frequent gaps ($1.8 mm or larger) of no staining at random positions along the nerve cords (Schaefer et al., 2000) ( Figure 3A ; Figure S3A ). In both zig-10 mutants, we observed significantly more presynaptic UNC-10 puncta than in wild-type animals, accompanied with fewer gaps lacking UNC-10 staining (Figures 3A-3C ; Figures  S3B-S3G ). The size and intensity of individual UNC-10 puncta were similar between zig-10 mutants and wild-type ( Figures 3D  and 3E ). The ultrastructural organization of zig-10(0) synapses appeared normal ( Figures S3H and S3I ). Expression of GFP::ZIG-10 under its endogenous promoter fully rescued the excessive number of synapses in zig-10 mutant animals ( Figures  3C-3E ; Figures S3C-S3E) . Thus, the normal function of ZIG-10 is to constrain synapse density.
ZIG-10 Specifically Constrains Density of Cholinergic Synapses
We next determined whether zig-10(0) differentially affected the NMJs formed by cholinergic and GABAergic neurons. We analyzed several presynaptic markers driven by motor neuronspecific promoters, including the active zone protein ELKS-1, or the synaptic vesicle proteins RAB-3 and SNB-1/Synaptobrevin (Table S2) . zig-10(0) animals showed more cholinergic synapses (Figures 4A, 4B, and 5B) but displayed normal numbers of GABAergic synapses (Figures 4C and 4D; Figures S4A and S4B) . Moreover, zig-10(0) animals showed an increase in both levamisole-sensitive (UNC-63-containing) and nicotine-sensitive (ACR-16-containing) acetylcholine receptors expressed in the muscle (Figures 4E and 4F; Figures S4C and S4D) . The increase of acetylcholine receptors correlated with a hypersensitivity to levamisole ( Figure S4E ), an agonist for UNC-63-containing acetylcholine receptors (Brenner, 1974; Lewis et al., 1980) . In contrast, we detected no noticeable differences for the muscle GABA receptor UNC-49 ( Figures 4F and 4G ). The increase in cholinergic synapse number correlated with the enhanced convulsions of zig-10(0); acr-2(gf) animals. Although acr-2(gf) animals displayed increased cholinergic activity, the number of NMJs was normal ( Figure 3F ) (Jospin et al., 2009) . zig-10(0); acr-2(gf) animals displayed an increase in synapses similar to zig-10(0) animals ( Figure 3F ), suggesting that the increased cholinergic synapses caused further imbalance between excitation and inhibition. Together, these data show that zig-10 specifically limits the number of cholinergic NMJs.
Epidermal and Cholinergic ZIG-10 Is Required for Synapse Maintenance
To address in which tissues zig-10 acts, we transgenically expressed ZIG-10 in specific tissues both in the zig-10(0); acr-2(gf) background, assaying convulsion behavior for a functional readout, and in zig-10(0) animals assaying anatomical effect by synapse number. Transgenic overexpression of GFP::ZIG-10 under its endogenous promoter was sufficient to reduce the convulsion frequency of zig-10(0); acr-2(gf) to acr-2(gf) single mutant levels ( Figure 5A ). Overexpression of ZIG-10 in acr-2(gf) alone or in wild-type background did not cause detectable locomotor phenotypes (Figure 5A ; data not shown). Expression of GFP::ZIG-10 in either cholinergic motor neurons (Punc-17b), adult epidermis (Pcol-19), or muscle (Pmyo-3) did not show any rescuing activity (Figure 5A ). Simultaneous expression of GFP::ZIG-10 in both the epidermis and cholinergic motor neurons, however, was sufficient to fully rescue the behavioral effects of zig-10(0). In contrast, simultaneous expression of ZIG-10 in both the muscle and cholinergic motor neurons or in both the muscle and epidermis failed to rescue ( Figure 5A ). Consistent with the functional outcome, the increased synapse number in zig-10(0) adult animals was reduced to wild-type levels only when ZIG-10 was expressed simultaneously in cholinergic motor neurons and the epidermis, but not when ZIG-10 was expressed in either tissue alone ( Figure 5B ). Furthermore, simultaneous expression of ZIG-10 in cholinergic motor neurons and in the epidermis fully rescued the increased UNC-63::YFP expression in zig-10(0) animals, suggesting that ZIG-10 may influence the levels of postsynaptic acetylcholine receptors indirectly through its function in regulating presynaptic or epidermal compartments ( Figure 5C ). To address whether the expression of ZIG-10 in the epidermis or cholinergic neurons could be dependent on each other, we analyzed the localization of GFP::ZIG-10 expressed in cholinergic neurons or the epidermis in wild-type and zig-10(0) animals. We observed that epidermal and cholinergic ZIG-10 localization near synapses marked by UNC-10 was significantly reduced in zig-10(0), compared to wild-type ( Figure S4F ). Additionally, epidermal ZIG-10 expression in zig-10(lf), which contains an amino acid substitution in the Ig1 domain, did not rescue the convulsion phenotype (Figure S4G) . Thus, the requirement for ZIG-10 co-expression in epidermis and neurons suggests that ZIG-10 could act as a homophilic molecule and that its function involves the first Ig domain.
ZIG-10 Functions Continuously throughout Development and Adult zig-10(0); acr-2(gf) animals displayed an enhanced convulsion frequency from larvae to adults ( Figure S5A ). ZIG-10 driven by the col-19 promoter was only expressed during and after late larval (L4) molting into adult and persisted into at least 3-day-old adults ( Figure S5C ; data not shown). In the presence of cholinergic ZIG-10, Pcol-19-GFP::ZIG-10 showed rescue of the synaptic phenotype in zig-10(0) from day 1 to day 3 adults (Figures S5E and S5F) . However, we observed that larval (L3) zig-10(0) animals that co-expressed ZIG-10 in the adult epidermis (Pcol-19) and in cholinergic motor neurons (Punc17b) did not show rescue of the synapse phenotype ( Figures  S5E and S5F ). To further test whether ZIG-10 is required continuously for synapse maintenance during development, we co-expressed ZIG-10 in cholinergic motor neurons using Punc-17b and larval epidermis using Pdpy-7, which is active in embryonic and larval epidermis but not in adult epidermis ( Figure S5B ). We observed that this expression was sufficient to restore synapses to wild-type levels in larval zig-10(0) animals but not in adults ( Figures S5E and S5F) . Interestingly, GFP::ZIG-10 expressed in larval epidermis was rapidly diminished by the onset of adulthood, compared to free GFP (Figure S5D) , suggesting that ZIG-10 protein might undergo rapid degradation. Together, these data show that ZIG-10 is required continuously to maintain synapse number in developing and adult animals.
Ectopic ZIG-10 in GABAergic Neurons Decreases Synapse Number ZIG-10 is not expressed in GABAergic motor neurons (Figure S2G) , which also closely associate with the epidermis and form synapses onto the same muscles as the cholinergic neurons (White et al., 1976) . To determine whether ZIG-10 is sufficient to modulate GABAergic synapse density, we ectopically expressed ZIG-10 in GABAergic neurons (Punc-25, designated P GABA -ZIG-10). In a wild-type background, we observed a reduction in GABAergic synapse number and an increase in UNC-10-negative stained gaps (Figures 6A and 6B; Figures S6A and S6B) . This ectopic expression of P GABA -ZIG-10 also caused a significant increase in convulsion frequency in acr-2(gf) ( Figure 6C ). However, in zig-10(0) animals P GABA -ZIG-10 expression did not alter GABAergic synapse density, nor did it affect the convulsion frequency of zig-10(0); acr-2(gf) ( Figures  6B and 6C) . Moreover, in zig-10(0); acr-2(gf) animals, ectopic expression of ZIG-10 in both GABAergic neurons and in the epidermis (P GABA -ZIG-10+Pcol-19-ZIG-10) caused a further increase in convulsion frequency ( Figure 6C ). These results demonstrate that ZIG-10 is sufficient to prevent synapse formation and further support our conclusion that ZIG-10 mediates an epidermal-neuronal homophilic interaction.
SRC-2 Kinase Functions Downstream of ZIG-10
To determine how ZIG-10 functions, we analyzed two ZIG-10 truncation mutants: ZIG-10-DICD, which removes the entire intracellular domain (45 amino acids) and ZIG-10-DTM-ICD, which removes both the transmembrane and intracellular domains ( Figure S7A ). Expression of ZIG-10-DICD or ZIG-10-DTM-ICD under its endogenous promoter in zig-10(0); acr-2(gf) did not rescue the enhanced convulsions ( Figure S7B ). We also expressed ZIG-10-DICD differentially in epidermis or neurons while providing wild-type ZIG-10 in the neuron or epidermis, respectively. Regardless of which cells expressed ZIG-10-DICD, neither combination was sufficient to provide full function of ZIG-10 ( Figure S7B ). These results suggest that ZIG-10 function depends on its intracellular domain to mediate signaling in both the epidermis and neurons.
We identified several predicted SH3 ligand motifs in the ZIG-10 intracellular domain ( Figure 1D ; Figure S1D ). We next searched for genes encoding SH3-containing proteins that might be required for ZIG-10 function by taking advantage of the enhanced convulsion frequency of adult animals of zig-10(0); acr-2(gf); Ex (Figures 6C  and 7A ; Tables S2 and S4). We reasoned that knockdown of such genes should reduce the convulsion frequency in these animals. The top hit identified in this screen was SRC-2, a Src family kinase (Table S4 ). We validated the RNAi effect using a src-2(0) null mutation ( Figure 7B ). src-2(0) single mutants had no obvious locomotor phenotype, but src-2(0); acr-2(gf) animals showed a significant increase in convulsion frequency, which was not further enhanced in src-2(0); zig-10(0); acr-2(gf) triple mutants ( Figure 7C ), suggesting that ZIG-10 and SRC-2 are in the same pathway. Moreover, using heterologous expression in HEK293T cells, we found that ZIG-10 and SRC-2 formed a complex as observed by co-immunoprecipitation ( Figure 7D ). Thus, SRC-2 interacts with ZIG-10 and functions downstream of ZIG-10. Since C. elegans neurons are generally refractory to RNAi (Kamath et al., 2001; Tavernarakis et al., 2000) and we were able to observe effects of src-2(RNAi) in a non-sensitized background, src-2 most likely functions in non-neuronal cells.
The Phagocytosis Pathway Functions Together with SRC-2 to Constrain Synapse Density Src kinases have been implicated in many pathways that modulate cell proliferation (Roche et al., 1995) , cell morphology (Yeatman, 2004) , and phagocytosis (Ziegenfuss et al., 2008) . In Drosophila, Src42A has been shown to regulate phagocytic activity of glial cells during axonal degeneration by phosphorylating the phagocytic receptor Draper (Ziegenfuss et al., 2008) . The C. elegans Draper ortholog CED-1 mediates phagocytosis of cell corpses and is expressed in the epidermis and motor neurons (Zhou et al., 2001 ). Similar to src-2(0); acr-2(gf) mutants, ced-1(0); acr-2(gf) mutants displayed an increase in convulsion frequency, which was not further enhanced in ced-1(0); zig-10(0); acr-2(gf) animals ( Figure 7C ). Importantly, epidermal, but not cholinergic, expression of CED-1::GFP completely rescued the ced-1(0); acr-2(gf) phenotype ( Figure 8A ). To address whether phosphorylation of CED-1 was required for CED-1 function, we expressed a mutant CED-1::GFP, in which tyrosine-1019, a conserved Src phosphorylation site, was mutated to phenylalanine (Y1019F) and found that epidermal expression of CED-1::GFP-Y1019F did not rescue the increased convulsion frequency of ced-1(0); acr-2(gf) (Figure 8A ), suggesting that CED-1 is likely a target of SRC-2.
In our RNAi screen for SH3-containing proteins, we also noticed moderate effects when knocking down ced-2 and ced-5 (Table S4) , which are components of the phagocytosis pathway known to function in clearing corpses of dying cells (Ellis et al., 1991) . We validated this observation using genetic mutations. We found that, similar to ced-1(0), loss of function in ced-2, ced-5, as well as ced-10 suppressed the enhanced convulsion frequency caused by ectopic ZIG-10 ( Figure 7B ). This analysis supports a conclusion that the phagocytosis pathway functions downstream of ZIG-10.
We next investigated whether CED-1 directly affected synapses. ced-1(0) animals produced an increased number of cholinergic synapses ( Figure 8B ), but ced-1(0); zig-10(0) animals displayed no further increase in cholinergic synapses as compared to zig-10(0) ( Figure 8B) . Furthermore, the reduction in GABAergic synapses caused by P GABA -ZIG-10 was abolished in ced-1(0) animals ( Figure 8C ). Together, these data support a conclusion that the phagocytosis pathway acts downstream of ZIG-10 to regulate synapse density.
ZIG-10 Regulates CED-1-Mediated Phagocytosis in Epidermis
To determine how zig-10(0) altered synapse density, we next investigated where phagocytosis components were localized with regard to synapses. Using Pced-1-2xFYVE::GFP (Yu et al., 2008) as a marker of endosomes and phagosomes and mCherry::RAB-3 expressed only in cholinergic neurons, we observed that phagosomes were frequently localized close to or overlapping with presynaptic terminals ( Figure 8D ). Interestingly, zig-10(0) animals showed a significant decrease in the number of The data in (B) and (C) are represented as mean ± SEM. *p < 0.05, **p % 0.01, ***p % 0.001, and ****p % 0.0001. Sample size is shown within each bar. See also Figure S7 ; Table S4. GFP::2xFYVE-labeled phagosomes associated with cholinergic synapses (Figures 8D and 8F) .
We observed similar effects on CED-1. In the epidermis around the nerve cords, Pced-1-CED-1::GFP forms puncta and rings (Figure 8E ), resembling the CED-1-containing phagosomes in the intestine and gonad (Zhou et al., 2001 ). In zig-10(0) animals, the number of CED-1::GFP-labeled phagosomes in nerve cords was greatly reduced compared to wild-type animals ( Figures 8D-8F) ; however, there was no change in CED-1::GFP levels (data not shown). Conversely, ced-1(0) showed normal GFP::ZIG-10 expression levels and localization (data not shown). Taken together, these findings suggest that ZIG-10 modulates phagocytic activity through SRC-2 and CED-1 in the epidermis to maintain synapse density.
DISCUSSION
Synapse maintenance occurs in many forms to ensure the function of neural circuits. Our results reveal the small IgSF molecule ZIG-10 plays a highly specific role in maintenance of excitatory synapse number. ZIG-10 mediates an interaction between cholinergic neurons and epidermis, enabling phagocytic elimination of synapses by the epidermis. SRC-2 interacts with ZIG-10 and functions downstream of ZIG-10 to modulate synapse maintenance through the regulation of CED-1.
Roles of Ig Superfamily in Maintaining Synapses
Members of the IgSF control many aspects of neural development, such as axon outgrowth and guidance, synapse formation, and cellular avoidance (Aurelio et al., 2002; Hummel et al., 2003; Shen et al., 2004; Wang et al., 2002; Yamagata et al., 2003) . Most synaptic IgSF proteins contain at least three Ig domains, and some have been shown to mediate signaling pathways in both pre-and post-synaptic neurons during synapse formation (Yamagata et al., 2003) . Recent studies have shown that some synaptogenic IgSF proteins also regulate synapse maintenance. For example, after synapse formation, SynCAM levels correlate with hippocampal synapse number, and overexpression of SynCAM causes an increased number of synapses that are maintained as long as SynCAM is overexpressed (Robbins et al., 2010) . IgSF9 mediates homophilic binding but does not induce synapse formation; yet, knockout mice display a reduction in GABAergic synapses (Mishra et al., 2014) . Interestingly, IgSF9 appears to function solely as an adhesion molecule since removal of its intracellular domain does not alter its function or GABAergic synapse number. In Drosophila, an L1-type cell adhesion molecule Neuroglian functions in a heterophilic manner in the presynaptic neurons and binds to Ankyrin through its cytoplasmic tail to modulate the growth and stability of the neuromuscular junctions (Enneking et al., 2013) .
Here, we have found that ZIG-10, a member of the two-Ig domain transmembrane protein family constrains cholinergic synapses. Unlike other IgSF proteins that promote synapse formation by acting at pre-or post-synaptic sites, ZIG-10 does not mediate a trans-synaptic interaction since combined cholinergic and muscle expression of ZIG-10 failed to rescue zig-10(0). Instead, ZIG-10 function requires its simultaneous expression in neurons and non-synaptic partners, the epidermis. ZIG-10 localizes to the cell surface, and high levels of ZIG-10 are present at regions that border the synapses. Since loss of zig-10 causes an increase in cholinergic NMJ number, ZIG-10 may function to occlude the interactions between pre-synaptic neurons and post-synaptic muscle.
ZIG-10 Provides Specificity to Phagocytosis of Synapses
In mammals, synapses destined for elimination are degraded through phagocytosis by non-neuronal cells (Chung et al., 2013; Schafer et al., 2012; Stevens et al., 2007) . MEGF10, the mammalian homolog of CED-1, functions in astrocytes to eliminate excitatory and inhibitory synapses through phagocytosis in developing and mature circuits (Chung et al., 2013) . However, it remains unclear whether astrocytes differentially target synapses in a neuron-specific manner and how glial cells discriminate between excitatory and inhibitory synapses.
Here, our data suggest that cell-type-specific expression of IgSF transmembrane proteins provides one level of discrimination for excitatory versus inhibitory synapse maintenance. ZIG-10 mediates an interaction between the epidermis and cholinergic neurons to enable the elimination of cholinergic synaptic material by phagocytosis in the epidermis while sparing GABAergic synapses. Moreover, we show that the ZIG-10 pathway provides cellular specificity, since mis-expression of ZIG-10 in GABAergic neurons causes a decrease in GABAergic synapse number. One hypothesis is that ZIG-10 in the epidermis could recruit and activate SRC-2, which then would phosphorylate CED-1, in turn enabling phagocytosis. Since CED-1::GFP is still present on membranes near the nerve cords in zig-10(0) mutants, it suggests that ZIG-10 and SRC-2 function to regulate the downstream signaling of CED-1 rather than its localization near synapses. Further studies will be required to determine how ZIG-10 activates SRC-2 and how synapses are specified for elimination.
While C. elegans has only two-Ig domain transmembrane proteins, vertebrate and Drosophila genomes contain a greatly expanded set of transmembrane two-Ig domain proteins (Figure S1 ) (Rougon and Hobert, 2003) . Emerging evidence suggests that ZIG-10 homologs may also establish specific cellular connections (Carrillo et al., 2015; Tan et al., 2015) . The IgSF protein, neurofascin-155, is expressed by mammalian glial cells and regulates cholinergic synapse elimination at the neuromuscular junction (Roche et al., 2014) . Similar to ZIG-10, mammalian neurofascin-155, C. briggsae ZIG-10, and Drosophila DPR-8 also contain predicted SH3 ligand motifs, suggesting a conservation of downstream signaling pathways. Further, we speculate that differential expression of such two-Ig domain proteins may provide cell-type selectivity for how individual circuits retain robustness during development or in response to changes in neuronal activity or even disease.
EXPERIMENTAL PROCEDURES
Strains and Transgenes C. elegans strains were maintained at room temperature on nematode growth media (NGM) as previously described (Brenner, 1974) , except for RNAi experiments as detailed below. The wild-type strain is Bristol N2. All strains and alleles used in this study are described in Table S2 ; genotypes were confirmed by PCR for deletion alleles or by sequencing for point mutations and by restriction enzyme digestion. zig-10(gk144897) alters an Hpy188III site.
We generated extrachromosomal array transgenic lines as previously described (Mello et al., 1991) . We used Pttx-3-RFP (80 ng/ml), Pgcy-8-GFP (90 ng/ml), or Pmyo-2-mCherry (2 ng/ml) as coinjection markers. Expression constructs, transgenes, and strain genotypes are summarized in Tables S2  and S3 . In general, two independent transgenic lines were observed and quantitative data shown for one.
RNAi Screen
For the epidermal RNAi screen of transmembrane proteins, we used CZ14540 Pcol-19-RDE-1 (juIs346) III; rde-1(ne219)V (Xu and Chisholm, 2011) to construct CZ16323 juIs346 III; rde-1(ne219) V; acr-2(n2420 gf) X. Animals were synchronized by bleaching gravid adults, and subsequent L1 progeny were placed on NGM plates containing 5 mM IPTG and 25 mg/ml carbenicillin (Sigma) that had been seeded with RNAi-expressing HT115 bacteria (Kamath et al., 2003) . Three days later, adult animals were assessed by visual inspection for convulsion frequency; eight to ten animals were counted per RNAi clone for three biological replicates.
For the RNAi screen of SH3-domain containing proteins, adult animals of zig-10(0); acr-2(gf); juEx6249 (CZ20628) were placed on RNAi plates. Their adult progeny were scored visually for convulsion frequency; eight to ten animals were counted per RNAi clone for three biological replicates.
Whole-Mount Immunocytochemistry and Image Analysis
We followed a standard fixation procedure (Finney and Ruvkun, 1990 ) with minor modifications (Supplemental Experimental Procedures). All samples were imaged on a Zeiss LSM710 confocal microscope under identical settings. To quantify the number and size of presynaptic puncta labeled by anti-UNC-10/ RIM2, we analyzed images of dorsal cord over a 50 mm distance using the Analyze Particles function of NIH ImageJ. Synaptic gaps were defined as asynaptic regions lacking UNC-10 staining that were greater than 2 mm (Schaefer et al., 2000) ; these UNC-10-negative gaps were manually quantified using the Grid plugin in ImageJ with an area per point setting of 2 mm. Interpunctal distance was calculated using the Analyze Particles function of ImageJ to obtain the centroid mass for each punctum; the distance between puncta was then calculated.
For imaging of SNB-1::GFP, ELKS-1::Cerulean, or RAB-3::CFP, live worms were immobilized with 10 mM levamisole. The number of presynaptic terminals labeled by SNB-1::GFP, ELKS-1::Cerulean, or RAB-3::CFP was manually counted. For analysis of developmental regulation of synapse maintenance, the total number of presynaptic puncta in the axon was manually counted at L3, adult day 1, and adult day 3 stages.
To analyze the levamisole-sensitive acetylcholine receptors labeled by UNC-63::YFP(kr98) in which YFP was inserted to the endogenous genomic locus of unc-63 (Gendrel et al., 2009 ) and the GABA receptors labeled by transgenic UNC-49::GFP (Bamber et al., 1999) , L4 animals were placed in M9 on a 10% agarose pad with no anesthetics and were rolled to obtain a dorsal view of the dorsal nerve cord for imaging. Animals expressing Pmyo-3-ACR-16::GFP to label levamisole-insensitive acetylcholine receptors were immobilized with 10 mM levamisole and imaged as described. The images were then analyzed using the Analyze Particles function of NIH ImageJ to quantify the fluorescence intensity; all measurements were normalized to the measured area.
For imaging GFP::2xFYVE or CED-1::GFP in the vicinity of the dorsal nerve cord, L4 animals were rolled to image the animals from the dorsal aspect with no anesthetics. Images were captured through the entire depth of the dorsal cord using Punc-17b-RAB-3::mCherry or Punc-17b-mCherry as a neuronal marker for the dorsal cord. CED-1::GFP-labeled phagosomes were defined as ring-like structures that encompassed cholinergic neuronal structures visualized by Punc-17b-mCherry.
DNA Plasmid Construction
Pzig-10-GFP (pCZGY2615) was produced by cloning the 4.3 kb zig-10 promoter into the destination vector upstream of the attR1-chloramphenicol resistance gene-ccdB gene-attR2 cassette using the Gibson cloning method (Gibson et al., 2009 ). GFP with introns was then cloned into the Pzig-10-destination vector by LR reaction.
Full-length functional GFP::ZIG-10 (pCZGY2602) was generated by cloning the genomic locus of zig-10 from the WRM065cF08 fosmid in two pieces: the 4.3 kb zig-10 5 0 upstream sequence to amino acid 20 of ZIG-10 and amino acid 21 to 890 base pairs 3 0 downstream of the stop codon. Restriction enzyme sites were incorporated by PCR allowing for the insertion of monomeric GFP into zig-10 after amino acid 20. All tissue-specific zig-10 rescue plasmids were generated using GFP-ZIG-10 coding sequence cloned into pCR8-GW/TOPO from genomic DNA and subsequently cloned into Gateway destination vectors containing promoters of interest.
A cDNA clone (yk1568) for zig-10 was kindly provided by Y. Kohara. This clone contains the 5 0 splice leader sequence (SL1), the zig-10 coding sequence, and the 3 0 UTR and corresponds to the full-length transmembrane domain-containing ZIG-10. The zig-10 cDNA was cloned into pCR8-GW/TOPO; further cloning was performed using the Gateway system. ZIG-10 truncations (pCZGY2614 and pCZGY2619, respectively) were generated by PCR.
RNA Analysis of zig-10(tm6127) RNA was isolated from mixed stage worms from either wild-type or zig-10(tm6127) background using Trizol according to manufacturer's specifications. cDNA was generated using SuperScript First Strand Synthesis kit (Invitrogen). To determine the effect of zig-10(tm6127) deletion at the transcript level, we performed RT-PCR using primers (5 0 -ctgaatgagaggaagccacg-3 0 and 5 0 -aggagctaaccgaggatctg-3 0 ), and the corresponding DNA fragments were analyzed by sequencing. The zig-10(tm6127) deletion disrupts exon splicing and results in changes from amino acid 137-YFQKPKKVIIICFHPKHIEFSF-158, followed by premature termination.
Behavioral Analysis
For behavioral analysis, late larval (L4) worms were grown overnight at room temperature and transferred to a fresh plate the following day for analysis. For the levamisole sensitivity assay, worms were moved to fresh plates containing levamisole (1 mM in NGM; Sigma). To assess convulsion frequency in worms expressing acr-2(gf), we moved worms to a fresh plate and visually observed them for 90 s to quantify the convulsion frequency. A convulsion was defined as a visible shortening in length between nose and tail (Jospin et al., 2009; Stawicki et al., 2011) .
Cell Culture and Biochemistry HEK293T cells (ATCC) were grown in DMEM (Cell Gro) supplemented with 10% fetal calf serum (Life Technologies). GFP::ZIG-10, HA::ZIG-10, or HA::SRC-2 were transfected as indicated using Lipofectamine 2000 (Invitrogen) according to manufacturer's specifications. Two days after transfection, the cells were collected in lysis buffer (50 mM Tris-HCl [pH 7.5]; 1% Igepal CA-630; 150 mM NaCl). After clearing cellular debris by centrifugation, the lysates were subjected to immunoprecipitation using HA-microbeads (Miltenyi) according to manufacturer's specifications. The eluate from immunoprecipitation and 50 mg of lysate were separated by SDS-PAGE and transferred to PDVF membranes. Membranes were probed with antibodies against GFP (1:2,000, RRID: AB_303395, Abcam), HA (1:1000, RRID: AB_10691311, Cell Signaling), and actin (1:6000, RRID: AB_ 2336056, MPBio).
Statistical Analysis
All graphical data are presented as mean ± SEM. A two-tailed t test was used to compare data between two groups. All quantitative data involving more than two groups was compared using a one-way ANOVA for parametric data followed by a post hoc t test with Bonferroni's correction for multiple comparisons. For non-parametric data, means were compared using a Kruskal-Wallis test followed by Dunn's multiple comparison tests. p < 0.05 (*) was considered statistically significant. Power analysis was performed to attain sample sizes that would provide a beta error % 0.2.
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